BDSX: Roth Initiates Buy
Roth Capital initiates coverage on Biodesix with a Buy rating and a price target of $32
Roth Capital analyst Max Masucci initiates coverage on Biodesix (NASDAQ: BDSX ) with a Buy rating and announces Price Target of $32.
Roth Capital initiates coverage on Biodesix with a Buy rating and a price target of $32
Roth Capital analyst Max Masucci initiates coverage on Biodesix (NASDAQ: BDSX ) with a Buy rating and announces Price Target of $32.